203 related articles for article (PubMed ID: 30809224)
1. Identification of Soluble Mediators in IgG-Mediated Anaphylaxis via Fcγ Receptor: A Meta-Analysis.
Kow ASF; Chik A; Soo KM; Khoo LW; Abas F; Tham CL
Front Immunol; 2019; 10():190. PubMed ID: 30809224
[No Abstract] [Full Text] [Related]
2. Clinacanthus nutans aqueous leaves extract exerts anti-allergic activity in preclinical anaphylactic models via alternative IgG pathway.
Kow ASF; Khoo LW; Tan JW; Abas F; Lee MT; Israf DA; Shaari K; Tham CL
J Ethnopharmacol; 2023 Mar; 303():116003. PubMed ID: 36464074
[TBL] [Abstract][Full Text] [Related]
3. Pathways of anaphylaxis in the mouse.
Strait RT; Morris SC; Yang M; Qu XW; Finkelman FD
J Allergy Clin Immunol; 2002 Apr; 109(4):658-68. PubMed ID: 11941316
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond.
Nguyen SMT; Rupprecht CP; Haque A; Pattanaik D; Yusin J; Krishnaswamy G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360549
[TBL] [Abstract][Full Text] [Related]
5. Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset.
Olivera A; Dillahunt SE; Rivera J
Immunol Lett; 2013 Feb; 150(1-2):89-96. PubMed ID: 23337656
[TBL] [Abstract][Full Text] [Related]
6. Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reaction.
Yuasa T; Ono M; Watanabe T; Takai T
J Exp Med; 2001 Mar; 193(5):563-72. PubMed ID: 11238587
[TBL] [Abstract][Full Text] [Related]
7. Anaphylaxis: lessons from mouse models.
Finkelman FD
J Allergy Clin Immunol; 2007 Sep; 120(3):506-15; quiz 516-7. PubMed ID: 17765751
[TBL] [Abstract][Full Text] [Related]
8. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI.
Okayama Y; Hagaman DD; Metcalfe DD
J Immunol; 2001 Apr; 166(7):4705-12. PubMed ID: 11254731
[TBL] [Abstract][Full Text] [Related]
9. Human IgE-independent systemic anaphylaxis.
Finkelman FD; Khodoun MV; Strait R
J Allergy Clin Immunol; 2016 Jun; 137(6):1674-1680. PubMed ID: 27130857
[TBL] [Abstract][Full Text] [Related]
10. Cytokine enhancement of anaphylaxis.
Strait R; Morrist SC; Finkelman FD
Novartis Found Symp; 2004; 257():80-91; discussion 91-100, 276-85. PubMed ID: 15025393
[TBL] [Abstract][Full Text] [Related]
11. NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module.
Li X; Kwon O; Kim DY; Taketomi Y; Murakami M; Chang HW
Allergy; 2016 Feb; 71(2):198-209. PubMed ID: 26456627
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.
Ujike A; Ishikawa Y; Ono M; Yuasa T; Yoshino T; Fukumoto M; Ravetch JV; Takai T
J Exp Med; 1999 May; 189(10):1573-9. PubMed ID: 10330436
[TBL] [Abstract][Full Text] [Related]
13. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of anaphylaxis: lessons from studies with murine models.
Finkelman FD; Rothenberg ME; Brandt EB; Morris SC; Strait RT
J Allergy Clin Immunol; 2005 Mar; 115(3):449-57; quiz 458. PubMed ID: 15753886
[TBL] [Abstract][Full Text] [Related]
16. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.
Tsujimura Y; Obata K; Mukai K; Shindou H; Yoshida M; Nishikado H; Kawano Y; Minegishi Y; Shimizu T; Karasuyama H
Immunity; 2008 Apr; 28(4):581-9. PubMed ID: 18342553
[TBL] [Abstract][Full Text] [Related]
17. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells.
Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC
Front Immunol; 2018; 9():1244. PubMed ID: 29928276
[TBL] [Abstract][Full Text] [Related]
18. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
19. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
[TBL] [Abstract][Full Text] [Related]
20. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.
Strait RT; Morris SC; Finkelman FD
J Clin Invest; 2006 Mar; 116(3):833-41. PubMed ID: 16498503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
